US Patent 7696242 Hepatitis C inhibitor peptide analogs
Patent 7696242 was granted and assigned to Boehringer Ingelheim on April, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+40 characters)
Article
Patent abstract
Compounds of formula (I):
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Elise Ghiro0
Jean Rancourt0
Marc-André Poupart0
Montse Llinas-Brunet0
Murray D. Bailey0
Nathalie Goudreau0
Punit Bhardwaj0
Teddy Halmos0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07696242 Hepatitis C inhibitor peptide analogs US Patent 7696242 Hepatitis C inhibitor peptide analogs
Infobox
Patent Number
076962420
Patent Number
76962420
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076962420
Date of Patent
April 13, 2010
0Patent Application Number
111856160
Date Filed
July 19, 2005
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07696242 Hepatitis C inhibitor peptide analogs
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07696242
Date of patent
April 13, 2010
Patent application number
11185616
Date Filed
July 19, 2005
Patent primary examiner
Find more entities like US Patent 7696242 Hepatitis C inhibitor peptide analogs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
